INDIANAPOLIS, Feb. 28,
2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:
LLY) will participate in Leerink Partners Global Healthcare
Conference on March 10, 2025.
Lucas Montarce, Lilly executive vice president and chief
financial officer, will take part in a fireside chat at
9:20 a.m., Eastern time.
A live audio webcast will be available on the "Webcasts &
Presentations" section of Lilly's investor website at
https://investor.lilly.com/webcasts-and-presentations. A replay of
the presentation will be available on this same website for
approximately 90 days.
About Lilly
Lilly is a medicine company turning
science into healing to make life better for people around the
world. We've been pioneering life-changing discoveries for nearly
150 years, and today our medicines help tens of millions of people
across the globe. Harnessing the power of biotechnology, chemistry
and genetic medicine, our scientists are urgently advancing new
discoveries to solve some of the world's most significant health
challenges: redefining diabetes care; treating obesity and
curtailing its most devastating long-term effects; advancing the
fight against Alzheimer's disease; providing solutions to some of
the most debilitating immune system disorders; and transforming the
most difficult-to-treat cancers into manageable diseases. With each
step toward a healthier world, we're motivated by one thing: making
life better for millions more people. That includes delivering
innovative clinical trials that reflect the diversity of our world
and working to ensure our medicines are accessible and affordable.
To learn more, visit Lilly.com and Lilly.com/news, or
follow us on Facebook, Instagram, and LinkedIn. F-LLY
Trademarks and Trade Names
All trademarks or trade
names referred to in this press release are the property of the
company, or, to the extent trademarks or trade names belonging to
other companies are references in this press release, the property
of their respective owners. Solely for convenience, the trademarks
and trade names in this press release are referred to without the ®
and ™ symbols, but such references should not be construed as any
indicator that the company or, to the extent applicable, their
respective owners will not assert, to the fullest extent under
applicable law, the company's or their rights thereto. We do not
intend the use or display of other companies' trademarks and trade
names to imply a relationship with, or endorsement or sponsorship
of us by, any other companies.
Refer
to:
|
Ashley Hennessey;
gentry_ashley_jo@lilly.com; 317-416-4363 (Media)
|
|
Michael Czapar;
czapar_michael_c@lilly.com; 317-617-0983 (Investors)
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lilly-to-participate-in-leerink-partners-global-healthcare-conference-302387950.html
SOURCE Eli Lilly and Company